{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T09:07:36Z","timestamp":1721984856891},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CE"],"DOI":"10.2147\/ce.s6011","type":"journal-article","created":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T23:51:22Z","timestamp":1284508282000},"page":"13","source":"Crossref","is-referenced-by-count":2,"title":["Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect"],"prefix":"10.2147","author":[{"given":"Michael","family":"Lewiecki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,6]]},"container-title":["Core Evidence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=4965","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:01:44Z","timestamp":1477864904000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/intravenous-zoledronic-acid-for-the-treatment-of-osteoporosis-the-evid-peer-reviewed-article-CE"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ce.s6011","relation":{},"ISSN":["1555-175X"],"issn-type":[{"value":"1555-175X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}